Multidetector Computed Tomography During Combined Therapy for Pancreatic Adenocarcinoma

Clinical Gastroenterology and Hepatology

Volumn 6, Issue 8, 2008, Pages

  Morgan, Desiree E ^a   Texada, John C ^a   Canon, Cheri L ^a   Lockhart, Mark E ^a   Posey III, James A ^b   Vickers, Selwyn M ^c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; ERLOTINIB; FLUOROURACIL; GEFITINIB; GEMCITABINE; IRINOTECAN; OXALIPLATIN;

ATROPHY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CLINICAL EVALUATION; COMBINATION CHEMOTHERAPY; DIAGNOSTIC IMAGING; DRUG EFFECT; DRUG INTERMITTENT THERAPY; DUODENUM BLEEDING; FOOT DISEASE; HAND DISEASE; HUMAN; INTESTINE PERFORATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; PANCREAS ADENOCARCINOMA; RADIATION RESPONSE; REVIEW; TREATMENT OUTCOME; TUMOR GROWTH; VEIN OCCLUSION; VEIN THROMBOSIS;

EID: 47949094637     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.03.023     Document Type: Review

References (16)

1. Sa Cunha A., Rault A., Laurent C., et al. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas. J Am Coll Surg 201 (2005) 359-365
2. Cardenes H.R., Chiorean E.G., DeWitt J., et al. Locally advanced pancreatic cancer: current therapeutic approach. Oncologist 11 (2006) 612-623
3. Burris III H.A., Moore M.J., Andersen J., et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15 (1997) 2403-2413
4. Crane C.H., Ellis L.M., Abbruzzese J.L., et al. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol 24 (2006) 1145-1151
5. Iannitti D., Dipetrillo T., Akerman P., et al. Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer: a phase I study. Am J Clin Oncol 28 (2005) 570-575
6. Moore M.J., Goldstein D., Hamm J., et al. Erlotinib improves survival when added to gemcitabine in patients with advanced pancreatic cancer. A phase III trial of the National Cancer Institute of Canada Clinical Trials Group [NCIC-CTG]. Proc Am Soc Clin Oncol 23 (2005) 1a
7. Xiong H.Q., Rosenberg A., Lobuglio A., et al. Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II trial. J Clin Oncol 22 (2004) 2610-2616
8. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25 (2004) 581-611
9. Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20 (2002) 4368-4380
10. Lu D.S.K., Reber H.A., Krasny R.M., et al. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase thin-section helical CT. AJR Am J Roentgenol 168 (1997) 1439-1443
11. Tamm E.P., Loyer E.M., Faria S., et al. Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. Abdom Imaging 31 (2006) 568-574
12. McNulty N.J., Francis I.R., Platt J.F., et al. Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology 220 (2001) 97-102
13. Vargas R., Nino-Murcia M., Trueblood W., et al. MDCT in pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol 182 (2004) 419-425
14. Prokesh R.W., Schima W., Chow L.C., et al. Multidetector CT of pancreatic adenocarcinoma: diagnostic advances and therapeutic relevance. Eur Radiol 13 (2003) 2147-2154
15. Raptopoulos V., Steer M.L., Sheiman R.G., et al. The use of helical CT and CT angiography to predict vascular involvement from pancreatic cancer: correlation with findings at surgery. AJR Am J Roentgenol 168 (1997) 971-977
16. Saif M.W., Eloubeidi M.A., Russo S., et al. Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome. J Clin Oncol 23 (2005) 8679-8687